Mouse Anti-ANGPT2 Recombinant Antibody (clone 10D6) (CAT#: HPAB-0172-WJ)

Figure 1 Results of Ang2-Tie2 competition ELISA showing the Ang2-Tie2 binding inhibition level depending on the concentration of an anti-Ang2 antibody.

Figure 2 Results of immunoblotting showing the change in the level of Tie2 receptor and phosphorylated Tie2 receptor depending on the concentration of an anti-Ang2 antibody.

Figure 3 Results of immunoblotting showing the change in the level of Tie2 receptor and phosphorylated Tie2 receptor by an anti-Ang2 antibody compared to that of a control antibody (RG).

Figure 4 A graph showing the ratio of phosphorylated Tyr in Tie2 receptor.

Figure 5 Results of immunoblotting showing the phosphorylation level of proteins relating to downstream signaling of Tie2 receptor by treatment of an anti-Ang2 antibody.

Figure 6 Results of immunoblotting showing the phosphorylation level of Tie2 receptor and Akt relating to downstream signaling of Tie2 receptor by treatment of an anti-Ang2 antibody in an animal model.

Figure 7 The degree of binding between an anti-Ang2 antibody and Ang2.

Figure 8 The phosphorylation level of Akt relating to downstream signaling of Tie2 receptor by treatment of a humanized and affinity-matured anti-Ang2 antibody together with Ang2.

Figure 9 The inhibition of cancer cell (MKN45) growth by treatment with an anti-c-Met/anti-Ang2 bispecific antibody.

Figure 10 The inhibition of cancer cell (EBC1) growth by treatment with an anti-c-Met/anti-Ang2 bispecific antibody.